Keywords
Recurrent candidiasis
Candida
Intestinal dysbiosis
Intestinal microflora
Intestinal modulation
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: Relate to vulvovaginal candidiasis caused by intestinal dysbiosis. Bibliographic review: The intestinal microbiota is naturally made up of bacteria, fungi and genetic elements. These microorganisms live in a relationship of mutualism with the host and are fundamental to human well-being and health. However, the loss of this homeostasis favors the establishment of pathologies, including recurrent candidiasis. The relationship between recurrent vulvovaginitis and intestinal dysbiosis lies in the fact that the intestinal microbiota plays a fundamental role in maintaining the balance of the immune system and preventing Candida overgrowth. When intestinal dysbiosis occurs, the immune system is compromised, the intestinal mucosa loses its integrity, promoting an imbalance in the flora and making the body more susceptible to infections. Recurrent vulvovaginal candidiasis affects thousands of women every day and despite this impact on women's health, there is still no consensus on how this disease should be treated. Final considerations: It is important to understand the relationship between intestinal dysbiosis and recurrent candidiasis, in order to provide prevention, diagnosis and appropriate individualized treatment to offer quality of life to the many women who suffer from this condition.
References
ABALLEA S, et al. Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA. Health and Quality of Life Outcomes, 2013; 11(1): 169.
ARAUJO I, et al. Caracterização sistemática da resposta imune à infecção por Candida. Brazilian Journal of Health Review, 2020; 3(2): 3788–3803.
BRADLEY F, et al. The vaginal microbiome amplifies sex hormone-associated cyclic changes in cervicovaginal inflammation and epithelial barrier disruption. American Journal of Reproductive Immunology, 2018; 80(1): e12863.
CAMPINHO L, et al. Probióticos em mulheres com candidíase vulvovaginal: qual a evidência? Revista Portuguesa De Medicina Geral E Familiar, 2019; 35(6): 465–458.
CORDEIRO E, et al. Candidíase: dietoterapia e uso de cepas como adjuvantes no tratamento. Pesquisa, Sociedade e Desenvolvimento, 2022; 11(9): e24211931786.
DIOP K, et al. Exhaustive repertoire of human vaginal microbiota. Human Microbiome Journal, 2019; 11: 100051.
DURÁN AB et al. Reviewing the Composition of Vaginal Microbiota: Inclusion of Nutrition and Probiotic Factors in the Maintenance of Eubiosis. Nutrients, 2020; 12(2): 419.
FUKAZAWA EI. Influência da candidíase vulvovaginal recorrente na qualidade de vida. Tese de Doutorado. Universidade de São Paulo, 2018
GONÇALVES MA. Microbiota: implicações na imunidade e no metabolismo. 2014. Tese (Mestrado em Ciências Farmacêuticas) - Curso de Ciências Farmacêuticas - Universidade Fernando Pessoa, 2014.
JACOMINI E, et al. Candidíase vulvovaginal recorrente: uma visão geral das perspectivas atuais: Recurrent vulvovaginal candidiasis: a general overview of current perspectives. Brazilian Journal of Development, 2022; 8(9): 64680-64697.
LEMA VM. Candidíase vulvovaginal recorrente: desafios diagnósticos e de manejo no contexto de um país em desenvolvimento. Obstet Gynecol Int J, 2017; 7(5): 260.
MACENA MV. et al. Disbiose intestinal e suas correlações com candidíase de repetição. Pesquisa, Sociedade e Desenvolvimento, 2022; 16: e424111638346.
MORENO AL, AGUILERA M. Probióticos vaginais para saúde reprodutiva e disbiose relacionada: revisão sistemática e meta-análise. J Clin Med, 2021; 10(7): 1461.
PALUDO RM, MARIN D. Relação entre candidíase de repetição, disbiose intestinal e suplementação com probióticos: uma revisão. Revista Destaques Acadêmicos, 2018; 10(3).
PEIXOTO M, et al. Candidíase -uma revisão de literatura. Candidiasis - a literature review. Brazilian Journal of Surgery and Clinical Research, 2014; 8(2): 75–82.
PEREIRA LC. Candidíase vulvovaginal e perspectivas atuais: sintomas, diagnóstico laboratorial, prevalência das espécies, resistência à antifúngicos, novos fatores de risco associados e avaliação da recorrência. Tese (Doutorado) - Curso de Ciências Médicas. Universidade de Brasília, Brasília, 2021.
ROSATI D, et al. Recurrent Vulvovaginal Candidiasis: an immunological perspective. Microorganisms, 2020; 8(2): 144.
SACO GM e MOYA JM. Update on vaginal infections: Aerobic vaginitis and other vaginal abnormalities. Prog Obstet Ginecol, Zaragoza, 2019; 62(1): 72-78.
SANTOS C. et al. Candidíase vulvovaginal recorrente: o papel do enfermeiro. Revista Ibero-Americana de Humanidades, Ciências e Educação, 2021; 7(3): 470-483.
SETA F, et al. The Vaginal Microbiome: iii. the vaginal microbiome in various urogenital disorders. Journal Of Lower Genital Tract Disease, 2022; 26(1): 85-92.
ZHU Y, et al. Health- related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis. Health and Quality of Life Outcomes, 2016; 14(65):1-6.